Literature DB >> 6156324

Effect of dopamine on hepatosplanchnic blood flow.

W Angehrn, E Schmid, F Althaus, K Niedermann, M Rothlin.   

Abstract

Hepatosplanchnic blood flow (EHBF) was estimated with the single-injection method using indocyanine green in 10 patients without cardiac failure before and after 20 min of an intravenous infusion of dopamine. Five patients received 4 microgram/kg/min and another 5 patients 8 microgram/kg/min. The cardiac index (CI) was determined according to the Fick principle, and the arterio-hepatovenous oxygen difference (AV DO2 AO/HV) was measured. The mean increase in EHBF in the 10 patients was from 640 +/- 46 ml/min/m2 to 831 +/- 56 ml/min/m2 (p less than 0.001). The percentage of EHBF to CI increased from 24.1 +/- 2.0% to 26.4 +/- 1.6% (p less than 0.05). The mean AV DO2 AO/HV dropped from 49.6 +/- 3.8 ml/liter to 40.4+/- 2.9 ml/liter (p less than 0.005). We conclude that dopamine given at rates of 4 and 8 microgram/kg/min to patients whose hearts are well compensated increases hepatosplanchnic flow. Thus, the large increase in renal blood flow which occurs with dopamine is not at the expense of hepatosplanchnic blood flow.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156324     DOI: 10.1097/00005344-198005000-00004

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  5 in total

Review 1.  Monitoring the hepato-splanchnic region in the critically ill patient. Measurement techniques and clinical relevance.

Authors:  A Brinkmann; E Calzia; K Träger; P Radermacher
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440

2.  Blood flow redistribution by dopamine in the feline gastrointestinal tract.

Authors:  R Kullmann; W R Breull; K Wassermann; A Konopatzki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

3.  Dopamine antagonist effects on locomotor activity in naive and ethanol-treated FAST and SLOW selected lines of mice.

Authors:  E H Shen; J C Crabbe; T J Phillips
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

Review 4.  Clinical pharmacokinetic considerations in the treatment of increased intracranial pressure.

Authors:  G Heinemeyer
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

5.  Metabolic changes associated with malnutrition in the patients with multiple organ failure.

Authors:  J Sato; H Inaba; H Hirasawa; T Mizuguchi
Journal:  J Anesth       Date:  1993-07       Impact factor: 2.078

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.